Amlodipine Besylate/Rosuvastatin Calcium/Telmisartan

苯磺酸氨氯地平/瑞舒伐他汀钙/替米沙坦

Report date: 2024/05/22 20:00:38

Base Information

Drug NameAmlodipine Besylate/Rosuvastatin Calcium/Telmisartan
Drug Alias Name瑞舒伐他汀钙替米沙坦苯磺酸氨氯地平Rosuvastatin Calcium/Amlodipine Besylate/TelmisartanTelmisartan/Amlodipine Besylate/Rosuvastatin Calcium苯磺酸氨氯地平瑞舒伐他汀钙替米沙坦瑞舒伐他汀钙/替米沙坦/苯磺酸氨氯地平 +[11] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsHMG-CoA reductase inhibitorsVoltage-gated calcium channel blockers
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channelHMG-CoA reductase
Therapy Area/IndicationsHyperlipidemiasDyslipidemiasHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes Amlodipine BesylateTelmisartanRosuvastatin Calcium
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJeil Pharmaceutical Co LtdDaewon Pharmaceutical Co LtdYuhan Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJeil Pharmaceutical Co LtdDaewon Pharmaceutical Co LtdYuhan Corp
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasDyslipidemiasHypertension

Other Information

ATC CodeN/A
Related LinksN/A